Cargando…

Successful use of phlebotomy to treat severe secondary polycythemia due to chronic lung disease

Secondary polycythemia (SP) occurs as a result of increase erythropoietin levels most commonly as a result of tissue hypoxia. Symptoms such as erythromelalgia, pruritis, and bleeding, which are frequently seen in polycythemia vera (PV), do not commonly occur in SP. Phlebotomy is considered one of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuqua, Jacob, Reece, Josephine, Sofka, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215527/
https://www.ncbi.nlm.nih.gov/pubmed/34221292
http://dx.doi.org/10.4081/hr.2021.8961
_version_ 1783710260728430592
author Fuqua, Jacob
Reece, Josephine
Sofka, Sarah
author_facet Fuqua, Jacob
Reece, Josephine
Sofka, Sarah
author_sort Fuqua, Jacob
collection PubMed
description Secondary polycythemia (SP) occurs as a result of increase erythropoietin levels most commonly as a result of tissue hypoxia. Symptoms such as erythromelalgia, pruritis, and bleeding, which are frequently seen in polycythemia vera (PV), do not commonly occur in SP. Phlebotomy is considered one of the mainstays of therapy for PV but is rarely used for treatment of SP due to concern about worsening tissue hypoxia. We present the case of a patient with severe SP due to chronic hypoxic lung disease who presented with erythromelalgia, pruritis, and bleeding and was treated successfully with therapeutic phlebotomy. This case illustrates the importance of considering the use of therapeutic phlebotomy in symptomatic patients with severe SP.
format Online
Article
Text
id pubmed-8215527
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-82155272021-07-02 Successful use of phlebotomy to treat severe secondary polycythemia due to chronic lung disease Fuqua, Jacob Reece, Josephine Sofka, Sarah Hematol Rep Case Report Secondary polycythemia (SP) occurs as a result of increase erythropoietin levels most commonly as a result of tissue hypoxia. Symptoms such as erythromelalgia, pruritis, and bleeding, which are frequently seen in polycythemia vera (PV), do not commonly occur in SP. Phlebotomy is considered one of the mainstays of therapy for PV but is rarely used for treatment of SP due to concern about worsening tissue hypoxia. We present the case of a patient with severe SP due to chronic hypoxic lung disease who presented with erythromelalgia, pruritis, and bleeding and was treated successfully with therapeutic phlebotomy. This case illustrates the importance of considering the use of therapeutic phlebotomy in symptomatic patients with severe SP. PAGEPress Publications, Pavia, Italy 2021-06-09 /pmc/articles/PMC8215527/ /pubmed/34221292 http://dx.doi.org/10.4081/hr.2021.8961 Text en ©Copyright: the Author(s) https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution NonCommercial 4.0 License (CC BY-NC 4.0).
spellingShingle Case Report
Fuqua, Jacob
Reece, Josephine
Sofka, Sarah
Successful use of phlebotomy to treat severe secondary polycythemia due to chronic lung disease
title Successful use of phlebotomy to treat severe secondary polycythemia due to chronic lung disease
title_full Successful use of phlebotomy to treat severe secondary polycythemia due to chronic lung disease
title_fullStr Successful use of phlebotomy to treat severe secondary polycythemia due to chronic lung disease
title_full_unstemmed Successful use of phlebotomy to treat severe secondary polycythemia due to chronic lung disease
title_short Successful use of phlebotomy to treat severe secondary polycythemia due to chronic lung disease
title_sort successful use of phlebotomy to treat severe secondary polycythemia due to chronic lung disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215527/
https://www.ncbi.nlm.nih.gov/pubmed/34221292
http://dx.doi.org/10.4081/hr.2021.8961
work_keys_str_mv AT fuquajacob successfuluseofphlebotomytotreatseveresecondarypolycythemiaduetochroniclungdisease
AT reecejosephine successfuluseofphlebotomytotreatseveresecondarypolycythemiaduetochroniclungdisease
AT sofkasarah successfuluseofphlebotomytotreatseveresecondarypolycythemiaduetochroniclungdisease